Absci (ABSI) Change in Receivables (2024 - 2025)
Absci's (ABSI) quarterly Change in Receivables came in at -$1.0 million in Q4 2025, up 33.33% year-on-year from -$750000.0 in Q4 2024, and down 433.33% quarter-over-quarter from $300000.0 in Q3 2025.
Absci (ABSI) Change in Receivables (2024 - 2025) Analysis & Trends
Absci has disclosed Change in Receivables across 2 years of filings, most recently posting -$1.0 million for Q4 2025.
- Change in Receivables for Q4 2025 came in at -$1.0 million, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 207.12% YoY), and the FY2024 annual result was -$2.2 million, down 436.19% from the prior year.
- Change in Receivables came in at -$1.0 million for Q4 2025 at Absci, down from $300000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.4 million in Q3 2024 to a low of -$2.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | -684,000.00 |
| Jun 30, 2025 | -684,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -2.15 Mn |
| Mar 31, 2024 | -2.15 Mn |